Proton Therapy Market Report and Forecast 2025-2034
Description
The Proton Therapy Market attained a value of USD 1314.60 Million in 2024 . The market is further expected to grow in the forecast period of 2025-2034 at a CAGR of 12.40% , to reach USD 4231.13 Million by 2034 .
Proton Therapy: Introduction
Proton therapy is a type of radiation therapy that treats cancer with the help of positively charged ions (protons). It may also be used in the treatment of some noncancerous tumours or in conjunction with treatments like chemotherapy or surgery. Proton therapy has garnered high popularity owing to its minimal side effects when compared to conventional methods as doctors have better hold at controlling the site of energy accumulation.
Global Proton Therapy Market Analysis
The rising prevalence of cancer is a major factor leading to proton therapy market demand. While radiation has been a common part of cancer treatment, proton therapy is now gaining popularity owing to its minimal side effects when compared to traditional radiotherapy. It also facilitates the patients to continue with day-to-day lives owing to its painless nature.
The proton therapy market value is also anticipated to grow with increasing encouragement by regulatory authorities like American Society for Radiation Oncology (ASTRO) to apply the therapy on patients. Consequently, new age pharmaceutical companies are now dedicated to use the therapy. In September 2023, Shuttle Pharmaceuticals Holdings, Inc. conveyed their commitment to employ the treatment on patients at the Hampton University Proton Therapy Institute Prostate Cancer & Men's Health Fair.
The market is anticipated to grow with the rising set up proton system into the existing infrastructure. In October 2023, Hitachi launched Southeast Asia’s first proton therapy system in National Cancer Centre Singapore (NCCS). This system is equipped with four rotating gantries and a Real-time image Gating system for Proton Therapy (RGPT) to treat tumours in motion due to respiration. It is also enabled with advanced spot scanning technology to precisely irradiate tumors with compound shapes.
Global Proton Therapy Market Segmentation
Global Proton Therapy Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type Accelerators Cyclotrons Synchrotrons
Beam Delivery Pencil Beam Scanning Passive Scattering Uniform Scanning
Modulators
Others Cyclotrons
Synchrotrons
Synchrocyclotrons
Linacs
H-Minus Synchrotrons
Separated Sector Cyclotrons
Super-Conducting Cyclotrons
Fast Cycling Synchrotron The Passive Scattering Technique
Beam Scanning Pencil Scanning Nozzle
Single Scattering
Double Scattering
Uniform Scanning Nozzle Ediatric Cancer
Tumours in the Base of the Skull
Prostate Cancer
Head and Neck Cancer
Breast Cancer
Lung Cancer
Tumours Affecting Spine
Eye Melanoma
Lymphoma
Pituitary Gland Tumours
Others
The United States alone is expected to record around 1,958,310 new cancer cases in 2023, hence, it is anticipated to hold a major part of the global proton therapy market share in upcoming years. Having a well-structured infrastructure that can easily adopt newer technologies is another essential component of the large market size. The region is experiencing validation from numerous upcoming companies which are willingly adapting to the latest techniques and devising better means of application.
Having several academic and healthcare institutions at home, Europe holds a massive market share as well. With the help of numerous awareness and educational campaigns, there is emphasis on educating the healthcare staff with the technical knowledge of using all the latest technologies.
The Asia Pacific region, on the other hand, is projected to encounter an upswing in the proton therapy market growth in the foreseeable future. With high national and foreign investments, emerging markets like India are continuously improving their research and healthcare infrastructure. Major healthcare companies are also investing in the Asian markets to leverage the easy availability of resources present in the region.
Global Proton Therapy Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Proton Therapy: Introduction
Proton therapy is a type of radiation therapy that treats cancer with the help of positively charged ions (protons). It may also be used in the treatment of some noncancerous tumours or in conjunction with treatments like chemotherapy or surgery. Proton therapy has garnered high popularity owing to its minimal side effects when compared to conventional methods as doctors have better hold at controlling the site of energy accumulation.
Global Proton Therapy Market Analysis
The rising prevalence of cancer is a major factor leading to proton therapy market demand. While radiation has been a common part of cancer treatment, proton therapy is now gaining popularity owing to its minimal side effects when compared to traditional radiotherapy. It also facilitates the patients to continue with day-to-day lives owing to its painless nature.
The proton therapy market value is also anticipated to grow with increasing encouragement by regulatory authorities like American Society for Radiation Oncology (ASTRO) to apply the therapy on patients. Consequently, new age pharmaceutical companies are now dedicated to use the therapy. In September 2023, Shuttle Pharmaceuticals Holdings, Inc. conveyed their commitment to employ the treatment on patients at the Hampton University Proton Therapy Institute Prostate Cancer & Men's Health Fair.
The market is anticipated to grow with the rising set up proton system into the existing infrastructure. In October 2023, Hitachi launched Southeast Asia’s first proton therapy system in National Cancer Centre Singapore (NCCS). This system is equipped with four rotating gantries and a Real-time image Gating system for Proton Therapy (RGPT) to treat tumours in motion due to respiration. It is also enabled with advanced spot scanning technology to precisely irradiate tumors with compound shapes.
Global Proton Therapy Market Segmentation
Global Proton Therapy Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
- Systems
- Software
- Services
- Proton Accelerator
- Beam Delivery System
- Nozzle
- Image Viewers
- Beam Transport System
- Patient Positioning System (PPS)
- Rotating Proton Therapy Systems
- Non-Rotating Proton Therapy Systems
- Multi-Room Systems
- Single-Room Systems
- Treatment Applications
- Research Applications
- Hospitals
- Ambulatory Surgical Centres
- Cancer Research Institutes
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The United States alone is expected to record around 1,958,310 new cancer cases in 2023, hence, it is anticipated to hold a major part of the global proton therapy market share in upcoming years. Having a well-structured infrastructure that can easily adopt newer technologies is another essential component of the large market size. The region is experiencing validation from numerous upcoming companies which are willingly adapting to the latest techniques and devising better means of application.
Having several academic and healthcare institutions at home, Europe holds a massive market share as well. With the help of numerous awareness and educational campaigns, there is emphasis on educating the healthcare staff with the technical knowledge of using all the latest technologies.
The Asia Pacific region, on the other hand, is projected to encounter an upswing in the proton therapy market growth in the foreseeable future. With high national and foreign investments, emerging markets like India are continuously improving their research and healthcare infrastructure. Major healthcare companies are also investing in the Asian markets to leverage the easy availability of resources present in the region.
Global Proton Therapy Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Varian Medical Systems, Inc.
- IBA Group
- Hitachi, Ltd.
- Mevion Medical Systems, Inc.
- Sumitomo Heavy Industries, Ltd.
- Optivus Proton Therapy, Inc.
- ProTom International, Inc.
- Advanced Oncotherapy Plc.
- ProNova Solutions, LLC
- Mitsubishi Electric Corporation
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Proton Therapy Market Overview
- 3.1 Global Proton Therapy Market Historical Value (2018-2024)
- 3.2 Global Proton Therapy Market Forecast Value (2025-2034)
- 4 Global Proton Therapy Market Landscape
- 4.1 Global Proton Therapy Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Proton Therapy Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Technology
- 4.2.3 Analysis by Application
- 5 Global Proton Therapy Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Proton Therapy Market Segmentation
- 6.1 Global Proton Therapy Market by Product Type
- 6.1.1 Market Overview
- 6.1.2 Systems
- 6.1.2.1 Accelerators
- 6.1.2.1.1 Cyclotrons
- 6.1.2.1.2 Synchrotrons
- 6.1.2.2 Beam Delivery
- 6.1.2.2.1 Pencil Beam Scanning
- 6.1.2.2.2 Passive Scattering
- 6.1.2.2.3 Uniform Scanning
- 6.1.2.3 Modulators
- 6.1.2.4 Others
- 6.1.3 Software
- 6.1.4 Services
- 6.2 Global Proton Therapy Market by Components
- 6.2.1 Market Overview
- 6.2.2 Proton Accelerator
- 6.2.2.1 Cyclotrons
- 6.2.2.2 Synchrotrons
- 6.2.2.3 Synchrocyclotrons
- 6.2.2.4 Linacs
- 6.2.2.5 H-Minus Synchrotrons
- 6.2.2.6 Separated Sector Cyclotrons
- 6.2.2.7 Super-Conducting Cyclotrons
- 6.2.2.8 Fast Cycling Synchrotron
- 6.2.3 Beam Delivery System
- 6.2.3.1 The Passive Scattering Technique
- 6.2.3.2 Beam Scanning
- 6.2.4 Nozzle
- 6.2.4.1 Pencil Scanning Nozzle
- 6.2.4.2 Single Scattering
- 6.2.4.3 Double Scattering
- 6.2.4.4 Uniform Scanning Nozzle
- 6.2.5 Image Viewers
- 6.2.6 Beam Transport System
- 6.2.7 Patient Positioning System (PPS)
- 6.3 Global Proton Therapy Market by Type
- 6.3.1 Market Overview
- 6.3.2 Rotating Proton Therapy Systems
- 6.3.3 Non-Rotating Proton Therapy Systems
- 6.4 Global Proton Therapy Market by Set-Up Systems
- 6.4.1 Market Overview
- 6.4.2 Multi-Room Systems
- 6.4.3 Single-Room Systems
- 6.5 Global Proton Therapy Market by Applications
- 6.5.1 Market Overview
- 6.5.2 Treatment Applications
- 6.5.2.1 Ediatric Cancer
- 6.5.2.2 Tumours In the Base of The Skull
- 6.5.2.3 Prostate Cancer
- 6.5.2.4 Head and Neck Cancer
- 6.5.2.5 Breast Cancer
- 6.5.2.6 Lung Cancer
- 6.5.2.7 Tumours Affecting Spine
- 6.5.2.8 Eye Melanoma
- 6.5.2.9 Lymphoma
- 6.5.2.10 Pituitary Gland Tumours
- 6.5.2.11 Others
- 6.5.3 Research Applications
- 6.6 Global Proton Therapy Market by End User
- 6.6.1 Market Overview
- 6.6.2 Hospitals
- 6.6.3 Ambulatory Surgical Centers
- 6.6.4 Cancer Research Institutes
- 6.6.5 Others
- 6.7 Global Proton Therapy Market by Region
- 6.7.1 Market Overview
- 6.7.2 North America
- 6.7.3 Europe
- 6.7.4 Asia Pacific
- 6.7.5 Latin America
- 6.7.6 Middle East and Africa
- 7 North America Proton Therapy Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Proton Therapy Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Proton Therapy Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Proton Therapy Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Proton Therapy Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 Varian Medical Systems, Inc.
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisition
- 17.1.5 Certifications
- 17.2 IBA Group
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisition
- 17.2.5 Certifications
- 17.3 Hitachi, Ltd.
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisition
- 17.3.5 Certifications
- 17.4 Mevion Medical Systems, Inc.
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisition
- 17.4.5 Certifications
- 17.5 Sumitomo Heavy Industries, Ltd.
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisition
- 17.5.5 Certifications
- 17.6 Optivus Proton Therapy, Inc.
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisition
- 17.6.5 Certifications
- 17.7 ProTom International, Inc.
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisition
- 17.7.5 Certifications
- 17.8 Advanced Oncotherapy Plc.
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisition
- 17.8.5 Certifications
- 17.9 ProNova Solutions, LLC
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisition
- 17.9.5 Certifications
- 17.10 Mitsubishi Electric Corporation
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisition
- 17.10.5 Certifications
- 18 Global Proton Therapy Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


